Ambrosia Biosciences Secures $100 Million in Oversubscribed Series B Round to Fuel Cardiometabolic Research Ambrosia Biosciences has completed a $100 million oversubscribed Series B financing to advance its innovative cardiometabolic therapies into clinical trials.

Ambrosia Biosciences Secures $100 Million in Oversubscribed Series B Round to Fuel Cardiometabolic Research #United_States #Boulder #cardiometabolic #Series_B_Financing #Ambrosia_Biosciences

EPG Secures Nearly $100 Million in Series B Funding to Expand Global Data Center Capabilities EPG has successfully completed its Series B funding round, raising nearly $100 million, significantly enhancing its global data center capabilities and operations.

EPG Secures Nearly $100 Million in Series B Funding to Expand Global Data Center Capabilities #Singapore #Data_Centers #Series_B_Financing #EPG

EQT Life Sciences Invests $44 Million in Cyted Health to Enhance US Market Reach EQT Life Sciences has led a $44 million Series B financing in Cyted Health, aiming to accelerate its US expansion and diagnostic innovations.

EQT Life Sciences Invests $44 Million in Cyted Health to Enhance US Market Reach #USA #Amsterdam #EQT_Life_Sciences #Cyted_Health #Series_B_Financing